{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:28:17Z","timestamp":1790742497893,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.jinf.2007.05.180","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T07:18:31Z","timestamp":1184656711000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Daptomycin"],"prefix":"10.1016","volume":"55","author":[{"given":"David A.","family":"Enoch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine M.","family":"Bygott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Andreas","family":"Karas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jinf.2007.05.180_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/502522","article-title":"The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges","volume":"26","author":"Cosgrove","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2007.05.180_bib3","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.jinf.2007.05.180_bib4","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1128\/AAC.49.9.3982-3983.2005","article-title":"Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus","volume":"49","author":"Wootton","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"7229","key":"10.1016\/j.jinf.2007.05.180_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bmj.320.7229.213","article-title":"Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis","volume":"320","author":"Reacher","year":"2000","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jac\/46.4.523","article-title":"Development of daptomycin for gram-positive infections","volume":"46","author":"Tally","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jac\/49.3.467","article-title":"In vitro bactericidal activity of daptomycin against staphylococci","volume":"49","author":"Fuchs","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.jinf.2007.05.180_bib8","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","article-title":"Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus","volume":"47","author":"Silverman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2007.05.180_bib9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/AAC.34.6.1220","article-title":"Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)","volume":"34","author":"Canepari","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","article-title":"In vivo pharmacodynamic activity of daptomycin","volume":"48","author":"Safdar","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1128\/AAC.46.1.31-33.2002","article-title":"Pharmacokinetics and inflammatory fluid penetration of intravenous daptomycin in volunteers","volume":"46","author":"Wise","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/AAC.40.1.203","article-title":"Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration","volume":"40","author":"Michiels","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijantimicag.2003.12.014","article-title":"Daptomycin in vitro susceptibility in European Gram-positive clinical isolates","volume":"24","author":"Fluit","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jinf.2007.05.180_bib14","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1128\/AAC.45.6.1919-1922.2001","article-title":"In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers","volume":"45","author":"Barry","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0732-8893(00)00164-4","article-title":"Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests","volume":"38","author":"Fuchs","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib16","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/AAC.44.4.1062-1066.2000","article-title":"In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains","volume":"44","author":"Rybak","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2007.05.180_bib17","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.44.12.3447-3450.2000","article-title":"Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens","volume":"44","author":"Snydman","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/48.4.563","article-title":"Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint","volume":"48","author":"Wise","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2007.05.180_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/48.2.219","article-title":"The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates","volume":"48","author":"King","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.jinf.2007.05.180_bib20","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/AAC.46.8.2595-2601.2002","article-title":"In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens","volume":"46","author":"Petersen","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2007.05.180_bib21","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/AAC.47.5.1689-1693.2003","article-title":"Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000\u20132001","volume":"47","author":"Critchley","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkg130","article-title":"Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000\u20132001","volume":"51","author":"Critchley","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkg288","article-title":"The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species","volume":"52","author":"Richter","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkh143","article-title":"Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms","volume":"53","author":"Streit","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2007.05.180_bib25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijantimicag.2004.03.010","article-title":"In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey","volume":"23","author":"Arslan","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/j.jinf.2007.05.180_bib26","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1128\/AAC.00286-06","article-title":"In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections","volume":"50","author":"Goldstein","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1179\/joc.2008.18.1.27","article-title":"In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci","volume":"18","author":"Cilli","year":"2006","journal-title":"J Chemother"},{"issue":"8","key":"10.1016\/j.jinf.2007.05.180_bib28","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/AAC.00272-06","article-title":"In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals","volume":"50","author":"Denis","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2007.05.180_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diagmicrobio.2004.06.014","article-title":"Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline","volume":"50","author":"LaPlante","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2007.05.180_bib30","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1128\/AAC.00526-06","article-title":"In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains","volume":"50","author":"Diederen","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2004.07.002","article-title":"Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide","volume":"50","author":"Sader","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2007.05.180_bib32","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/AAC.47.6.1968-1971.2003","article-title":"In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria","volume":"47","author":"Goldstein","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.47.1.337-341.2003","article-title":"In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates","volume":"47","author":"Goldstein","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2007.05.180_bib34","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1128\/AAC.48.6.2149-2152.2004","article-title":"In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp","volume":"48","author":"Goldstein","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jinf.2007.05.180_bib35","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1128\/AAC.00357-06","article-title":"In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes","volume":"50","author":"Tyrrell","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib36","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1128\/AAC.01352-06","article-title":"Daptomycin susceptibility of unusual gram-positive bacteria: comparison of the Etest and Broth Microdilution Method","volume":"51","author":"Huang","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2007.05.180_bib37","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/jac\/dkh198","article-title":"Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar","volume":"53","author":"Johnson","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jinf.2007.05.180_bib38","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","article-title":"Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Hayden","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.jinf.2007.05.180_bib39","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1128\/JCM.00665-06","article-title":"Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates","volume":"44","author":"Jevitt","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.jinf.2007.05.180_bib40","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1128\/AAC.01491-05","article-title":"Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin","volume":"50","author":"Sader","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jac\/48.4.557","article-title":"Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media","volume":"48","author":"Fuchs","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2007.05.180_bib42","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JCM.00076-06","article-title":"Assessment of two commercial susceptibility test methods for determination of daptomycin MICs","volume":"44","author":"Jorgensen","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijantimicag.2003.06.002","article-title":"Comparison of daptomycin MIC results by DIN, NCCLS, SFM, and SRGA methods for 297 Gram-positive organisms","volume":"23","author":"Koeth","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"10.1016\/j.jinf.2007.05.180_bib44","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2007.05.180_bib45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dkh531","article-title":"Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections","volume":"55","author":"Lipsky","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2007.05.180_bib46","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1185\/030079906X148427","article-title":"Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry","volume":"22","author":"Martone","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"10.1016\/j.jinf.2007.05.180_bib47","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib48","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-97-4-496","article-title":"Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study","volume":"97","author":"Korzeniowski","year":"1982","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jinf.2007.05.180_bib49","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jinf.2006.11.007","article-title":"Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients","volume":"54","author":"Poutsiaka","year":"2007","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1592\/phco.26.3.347","article-title":"Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients","volume":"26","author":"Segreti","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.jinf.2007.05.180_bib51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.hrtlng.2004.07.009","article-title":"Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin","volume":"34","author":"Mohan","year":"2005","journal-title":"Heart Lung"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.hrtlng.2005.09.010","article-title":"Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: cure with prolonged\/high-dose daptomycin without toxicity","volume":"35","author":"Cunha","year":"2006","journal-title":"Heart Lung"},{"issue":"10","key":"10.1016\/j.jinf.2007.05.180_bib53","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1345\/aph.1G242","article-title":"Successful treatment of Corynebacterium striatum endocarditis with daptomycin plus rifampin","volume":"39","author":"Shah","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.jinf.2007.05.180_bib54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jac\/dki435","article-title":"Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis","volume":"57","author":"Rouse","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2007.05.180_bib55","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1185\/030079905X74961","article-title":"Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections","volume":"21","author":"Finney","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"10.1016\/j.jinf.2007.05.180_bib56","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1086\/430352","article-title":"Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact","volume":"191","author":"Silverman","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib57","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jhin.2005.10.001","article-title":"Community-onset healthcare-associated MRSA bacteraemia in a district general hospital","volume":"62","author":"Karas","year":"2006","journal-title":"J\u00a0Hosp Infect"},{"issue":"2\u20133","key":"10.1016\/j.jinf.2007.05.180_bib58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000085611","article-title":"In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections","volume":"51","author":"Wagenlehner","year":"2005","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib59","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkh104","article-title":"Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci","volume":"53","author":"Rand","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2007.05.180_bib60","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1128\/AAC.49.12.5166-5168.2005","article-title":"In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin","volume":"49","author":"Pankey","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jinf.2007.05.180_bib61","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/AAC.48.8.2871-2875.2004","article-title":"Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus","volume":"48","author":"Rand","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.jinf.2007.05.180_bib62","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/AAC.49.7.2735-2745.2005","article-title":"Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in\u00a0vitro pharmacodynamic model with simulated endocardial vegetations","volume":"49","author":"Tsuji","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2007.05.180_bib63","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/AAC.01455-06","article-title":"Activity of Daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus by time-kill methodology","volume":"51","author":"Credito","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib64","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jac\/dkh554","article-title":"In vivo synergy of daptomycin plus a penicillin agent for MRSA?","volume":"55","author":"Scheetz","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2007.05.180_bib65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/00365540500277292","article-title":"Daptomycin-rifampin for a recurrent MRSA joint infection unresponsive to vancomycin-based therapy","volume":"38","author":"Burns","year":"2006","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00365540500372697","article-title":"Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus","volume":"38","author":"Antony","year":"2006","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2007.05.180_bib67","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JCM.44.2.655-656.2006","article-title":"Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin","volume":"44","author":"Skiest","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2007.05.180_bib68","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","article-title":"Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis","volume":"44","author":"Marty","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2007.05.180_bib69","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jac\/dkl256","article-title":"Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy","volume":"58","author":"Mariani","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.jinf.2007.05.180_bib70","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1086\/428616","article-title":"Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia","volume":"40","author":"Mangili","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2007.05.180_bib71","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1128\/JCM.43.10.5384-5387.2005","article-title":"Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin","volume":"43","author":"Vikram","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib72","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/502688","article-title":"Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia","volume":"27","author":"Hirschwerk","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"10.1016\/j.jinf.2007.05.180_bib73","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.4065\/80.9.1215","article-title":"Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia","volume":"80","author":"Long","year":"2005","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib74","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1128\/AAC.49.4.1664-1665.2005","article-title":"Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy","volume":"49","author":"Lewis","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib75","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/432121","article-title":"Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection","volume":"41","author":"Munoz-Price","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1078155206069165","article-title":"Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans","volume":"12","author":"Green","year":"2006","journal-title":"J\u00a0Oncol Pharm Pract"},{"issue":"2","key":"10.1016\/j.jinf.2007.05.180_bib77","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1128\/JCM.44.2.673.2006","article-title":"De novo daptomycin nonsusceptibility in a clinical isolate","volume":"44","author":"Lesho","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.jinf.2007.05.180_bib78","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1128\/AAC.45.6.1799-1802.2001","article-title":"Resistance studies with\u00a0daptomycin","volume":"45","author":"Silverman","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2007.05.180_bib79","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.00039-06","article-title":"Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus","volume":"50","author":"Friedman","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib80","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced Daptomycin susceptibility and Vancomycin resistance in Vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib81","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.50.4.1581-1585.2006","article-title":"Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin","volume":"50","author":"Sakoulas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2007.05.180_bib82","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib83","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jac\/dki058","article-title":"Severe myopathy and possible hepatotoxicity related to daptomycin","volume":"55","author":"Echevarria","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2007.05.180_bib84","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/504379","article-title":"Rhabdomyolysis during therapy with daptomycin","volume":"42","author":"Papadopoulos","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2007.05.180_bib85","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jinf.2006.11.006","article-title":"Eosinophilic pneumonia induced by daptomycin","volume":"54","author":"Hayes","year":"2007","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.jinf.2007.05.180_bib86","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/383472","article-title":"Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens","volume":"38","author":"Carpenter","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445307006408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445307006408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:31:56Z","timestamp":1758987116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445307006408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0163445307006408"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2007.05.180","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daptomycin","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2007.05.180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}